Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.5.0.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Current Assets    
Cash and cash equivalents $ 3,214,065 $ 623,184
Restricted cash 113,990 325,832
Accounts receivable - project revenue and reimbursable project 83,219 139,797
Prepaid expenses and other current assets 135,222 168,029
Deferred financing cost, net 491,168
Total Current Assets 4,037,664 1,256,842
Other Assets    
Patent costs 1,121,771 950,594
Deferred financing cost, net 1,105,241
Total Assets 6,264,676 2,207,436
Current Liabilities    
Accounts payable and accrued liabilities 951,705 1,182,371
Note payable 27,377
Total Current Liabilities 979,082 1,182,371
Long-Term Liabilities    
Deferred lease abandonment liability 67,354 196,938
Derivative warrant liability 120,513 2,327,195
Total Liabilities 1,166,949 3,706,504
Stockholders' Equity (Deficiency)    
Preferred stock, $0.001 par value, 10,000,000 authorized shares, Convertible Series A Preferred Shares, $.001 par value, 1,020,000 issued and outstanding at September 30, 2016 and 0 shares outstanding at December 31, 2015 1,020
Common stock, $0.001 par value, 100,000,000 authorized, 5,183,231 shares outstanding at September 30, 2016 and 3,725,819 shares outstanding at December 31, 2015 5,183 3,726
Additional paid-in capital 82,598,391 72,868,647
Accumulated Deficit (77,506,867) (74,371,441)
Total Stockholders' Equity (Deficiency) 5,097,727 (1,499,068)
Total Liabilities and Stockholders' Equity (Deficiency) $ 6,264,676 $ 2,207,436